EE

Eddie Eltoukhy

Partner at Pear VC | Life Sciences Venture Investing

San Francisco Bay Area

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $250,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $5,000,000.00

Skills

Polymers
Polymer Chemistry
DNA
Gene Delivery
Drug Delivery
Nanoparticles
Transfection
Cell Culture
Flow Cytometry
Molecular Cloning
Biomedical Engineering
Biomaterials
Biotechnology
Nanotechnology
Confocal Microscopy
Biochemistry
In Vitro
ELISA
In Vivo
Spectroscopy

Education

Work Experience

Pear VC

2022

  • Partner

    2022

Senti Biosciences

2017 - 2022

  • Head Of Corporate Development

    2017 - 2022

Ionpath Inc.

2017 - 2017

  • Consultant

    2017 - 2017

NanoDimension

2016 - 2016

  • MBA Intern

    2016 - 2016

Roche

2016 - 2016

  • Business Development MBA Intern

    2016 - 2016

    Roche Partnering @ Genentech in SSF Focus on Immunology, Infectious Diseases, and Specialty Care

Kala Pharmaceuticals

2013 - 2015

  • Scientist

    2013 - 2015

Massachusetts Institute of Technology (MIT)

2007 - 2013

  • Postdoctoral Researcher

    2013 - 2013

  • PhD Candidate

    2007 - 2013

    Developed and characterized novel polymer and lipid-based materials for non-viral gene therapy. Advisors: Prof. Robert Langer and Prof. Daniel Anderson.

Stanford University School of Medicine

2005 - 2007

  • Research Intern

    2005 - 2007

    Collaborated with researchers to investigate the role of genetic factors in Parkinson’s disease as part of a large epidemiological study. Advisors: Prof. Lorene Nelson and Dr. Valerie McGuire.

NASA - National Aeronautics and Space Administration

2006 - 2006

  • Laboratory Assistant

    2006 - 2006

    Helped develop a technique to ascertain the diameter and height distribution of arrays of vertically-aligned carbon nanofibers for use in thermal interface materials. Advisor: Dr. Brett Cruden, NASA Ames Research Center, Center for Nanotechnology.